type 2 diabetes
Gene variant and glucose metabolism
Feb. 18, 2021—Genetic variation that impacts glucose- and insulin-related signaling affects responses to type 2 diabetes treatments and warrants further study.
Early research shows promise for therapeutics that delay Type 2 Diabetes
Jan. 12, 2021—Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans.
A cohort for type 2 diabetes studies
Nov. 17, 2020—A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.
Genetic screen in worms reveals critical step in insulin synthesis
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
Diabetes drug study explores cardiovascular risks for patients with kidney disease
Sep. 25, 2019—An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
My Southern Health: Myths about type 2 diabetes
Jul. 20, 2018—A diabetes expert sorts myth from fact when it comes to type 2 diabetes.
Study may point to new ways to reverse insulin resistance
Jan. 25, 2018—Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.
Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children
Jun. 22, 2017—In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.
Therapeutic targets for diabetes
May. 3, 2017—Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.
Diabetes management and low income
Apr. 6, 2016—Adherence to medication was the only self-care activity independently associated with glycemic control in a low-income population.
Fighting type 2 diabetes with FGF1
Nov. 18, 2015—The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.
Lymphocyte study reveals obesity clues
Oct. 16, 2014—Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.